skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: New Records: New From Last Week remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy
Material Type:
Article
Add to My Research

Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy

Journal of pharmacy & pharmaceutical sciences, 2024-04, Vol.27 [Peer Reviewed Journal]

EISSN: 1482-1826 ;DOI: 10.3389/jpps.2024.12568

Full text available

2
Effect of extruded djulis (Chenopodium formosanum) snacks on the ameliorative potential against diabetic cardiomyopathy
Material Type:
Article
Add to My Research

Effect of extruded djulis (Chenopodium formosanum) snacks on the ameliorative potential against diabetic cardiomyopathy

Journal of functional foods, 2024-05, Vol.116, p.106154 [Peer Reviewed Journal]

ISSN: 1756-4646 ;EISSN: 2214-9414

Full text available

3
Exosomal miR-9-5p derived from iPSC-MSCs ameliorates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence
Material Type:
Article
Add to My Research

Exosomal miR-9-5p derived from iPSC-MSCs ameliorates doxorubicin-induced cardiomyopathy by inhibiting cardiomyocyte senescence

Journal of nanobiotechnology, 2024-04, Vol.22 (1), p.195-19 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1477-3155 ;EISSN: 1477-3155 ;DOI: 10.1186/s12951-024-02421-8 ;PMID: 38643173

Full text available

4
Signal-averaged electrocardiography as a noninvasive tool for evaluating the ventricular substrate in patients with nonischemic cardiomyopathy: reassessment of an old tool
Material Type:
Article
Add to My Research

Signal-averaged electrocardiography as a noninvasive tool for evaluating the ventricular substrate in patients with nonischemic cardiomyopathy: reassessment of an old tool

Frontiers in cardiovascular medicine, 2024-04, Vol.11 [Peer Reviewed Journal]

EISSN: 2297-055X ;DOI: 10.3389/fcvm.2024.1306055

Full text available

5
Comparative analysis of health-related fitness in patients with acute versus chronic Chagas disease
Material Type:
Article
Add to My Research

Comparative analysis of health-related fitness in patients with acute versus chronic Chagas disease

Biomédica, 2024-03, Vol.44 (1), p.67-79 [Peer Reviewed Journal]

ISSN: 0120-4157 ;EISSN: 2590-7379 ;DOI: 10.7705/biomedica.6892

Full text available

6
Coronary microvascular dysfunction in childhood: An emerging pathological entity and its clinical implications
Material Type:
Article
Add to My Research

Coronary microvascular dysfunction in childhood: An emerging pathological entity and its clinical implications

American heart journal plus, 2024-06, Vol.42, p.100392 [Peer Reviewed Journal]

EISSN: 2666-6022

Full text available

7
Endoplasmic reticulum stress-related gene expression causes the progression of dilated cardiomyopathy by inducing apoptosis
Material Type:
Article
Add to My Research

Endoplasmic reticulum stress-related gene expression causes the progression of dilated cardiomyopathy by inducing apoptosis

Frontiers in genetics, 2024-04, Vol.15 [Peer Reviewed Journal]

EISSN: 1664-8021 ;DOI: 10.3389/fgene.2024.1366087

Full text available

8
A curious Takotsubo cardiomyopathy after COVID-19
Material Type:
Article
Add to My Research

A curious Takotsubo cardiomyopathy after COVID-19

IDCases, 2024-01, Vol.36, p.e01958 [Peer Reviewed Journal]

EISSN: 2214-2509

Full text available

9
Analysis of long-term prognosis and risk factors in patients with dilated cardiomyopathy
Material Type:
Article
Add to My Research

Analysis of long-term prognosis and risk factors in patients with dilated cardiomyopathy

Zhōnghuá xīnxuèguănbìng zázhì, 2024-04, Vol.52 (4), p.384

ISSN: 0253-3758 ;PMID: 38644253

Digital Resources/Online E-Resources

10
Applied Therapeutics (APLT: $4.48) tumbles 5.5%, 2 days' volume in a day; -26c [5.5%] Vol Index 2.0 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Applied Therapeutics (APLT: $4.48) tumbles 5.5%, 2 days' volume in a day; -26c [5.5%] Vol Index 2.0 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 20, 2024

Digital Resources/Online E-Resources

11
Tenaya Therapeutics (TNYA: $4.32) increases; +3c [0.7%]
Material Type:
Newsletter Article
Add to My Research

Tenaya Therapeutics (TNYA: $4.32) increases; +3c [0.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 20, 2024

Digital Resources/Online E-Resources

12
UPDATE: Cytokinetics (CYTK: $66.81) keeps sliding, down 3.2% in 3 days; -$2.19 [3.2%]
Material Type:
Newsletter Article
Add to My Research

UPDATE: Cytokinetics (CYTK: $66.81) keeps sliding, down 3.2% in 3 days; -$2.19 [3.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 20, 2024

Digital Resources/Online E-Resources

13
Intellia Therapeutics (NTLA: $21.57) rises 1.2% on increasing volatility; +25c [1.2%]
Material Type:
Newsletter Article
Add to My Research

Intellia Therapeutics (NTLA: $21.57) rises 1.2% on increasing volatility; +25c [1.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 20, 2024

Digital Resources/Online E-Resources

14
Solid Biosciences (SLDB: $8.70) falls in 4 out of last 5 days, 5-day fall of 16%; -56c [6.0%]
Material Type:
Newsletter Article
Add to My Research

Solid Biosciences (SLDB: $8.70) falls in 4 out of last 5 days, 5-day fall of 16%; -56c [6.0%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 20, 2024

Digital Resources/Online E-Resources

15
Lexeo Therapeutics (LXEO: $12.05) decreases; -2c [0.2%]
Material Type:
Newsletter Article
Add to My Research

Lexeo Therapeutics (LXEO: $12.05) decreases; -2c [0.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd Apr 20, 2024

Digital Resources/Online E-Resources

16
Transthyretin amyloid cardiomyopathy: acoramidis
Material Type:
magazinearticle
Add to My Research

Transthyretin amyloid cardiomyopathy: acoramidis

Manufacturing chemist (London : 1981), 2024-04, Vol.95 (4), p.30

COPYRIGHT 2024 HPCi Media Ltd. ;ISSN: 0262-4230

Digital Resources/Online E-Resources

17
Hypertrophic Cardiomyopathy Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Tenaya Therapeutics, Shandong
Material Type:
Newspaper Article
Add to My Research

Hypertrophic Cardiomyopathy Pipeline Review, 2024 Updates | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Tenaya Therapeutics, Shandong

M2 Presswire, 2024-04-18

COPYRIGHT 2024 Normans Media Ltd.

Digital Resources/Online E-Resources

18
Research progress on mitochondrial metabolic microenvironment and cardiac fibrosis
Material Type:
Article
Add to My Research

Research progress on mitochondrial metabolic microenvironment and cardiac fibrosis

Zhōnghuá xīnxuèguănbìng zázhì, 2024-04, Vol.52 (4), p.425

ISSN: 0253-3758 ;PMID: 38644259

Digital Resources/Online E-Resources

19
Editorial: Multi-omics in cardiomyopathies causing heart failure: from mechanism to treatment
Material Type:
Article
Add to My Research

Editorial: Multi-omics in cardiomyopathies causing heart failure: from mechanism to treatment

Frontiers in cardiovascular medicine, 2024-04, Vol.11 [Peer Reviewed Journal]

EISSN: 2297-055X ;DOI: 10.3389/fcvm.2024.1405813

Full text available

20
Diastolic dysfunction in aortic stenosis: Old pathophysiologic observations made a new tool
Material Type:
Article
Add to My Research

Diastolic dysfunction in aortic stenosis: Old pathophysiologic observations made a new tool

Echocardiography (Mount Kisco, N.Y.), 2024-04, Vol.41 (4), p.e15816 [Peer Reviewed Journal]

EISSN: 1540-8175 ;PMID: 38643458

Digital Resources/Online E-Resources

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait